Insulet Corp.
PODD
Rang in Aktien
#2092
Insulet Corporation develops, manufactures, and sells insulin delivery systems... Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes in the United States and internationally. The company offers Omnipod platform products comprising Omnipod 5 automated insulin delivery system, which includes a proprietary AID algorithm embedded in the pod that integrates with a third-party continuous glucose monitor to obtain glucose values through wireless Bluetooth communication; Omnipod DASH insulin management system that features a Bluetooth enabled pod that is controlled by a smartphone-like personal diabetes manager with a color touch screen user interface; and the Omnipod Insulin Management System. It also provides pods for Amgen for use in the Neulasta Onpro kit, which is a delivery system to help reduce the risk of infection after intense chemotherapy. The company sells its products to end-users through the pharmacy channel; and independent distributors. Insulet Corporation was incorporated in 2000 and is headquartered in Acton, Massachusetts.
Aktienkurs
$141.47
Marktkapitalisierung
$9.81B
Veränderung (1 Tag)
0.26%
Veränderung (1 Jahr)
-55.60%
Land
US
Handel Insulet Corp. (PODD)
Kategorie
Healthcare
P/S-Verhältnis für Insulet Corp. (PODD)
P/S-Verhältnis zum October 2026 TTM: 3.04
Laut den neuesten Finanzberichten und dem Aktienkurs von Insulet Corp. beträgt das aktuelle Kurs-Umsatz-Verhältnis (TTM) 3.04. Am Ende des Jahres 2023 lag das P/S-Verhältnis bei 8.92.
P/S-Verlauf für Insulet Corp. von 2002 bis 2026
P/S-Verhältnis zum Jahresende
| Jahr | P/S-Verhältnis | ändert |
|---|---|---|
| 2026 (TTM) | 3.04 | -65.55% |
| 2024 | 8.83 | -0.97% |
| 2023 | 8.92 | -43.00% |
| 2022 | 15.65 | -4.55% |
| 2021 | 16.39 | -10.41% |
| 2020 | 18.30 | 30.21% |
| 2019 | 14.05 | 69.71% |
| 2018 | 8.28 | -4.05% |
| 2017 | 8.63 | 48.27% |
| 2016 | 5.82 | -28.46% |
| 2015 | 8.14 | -8.32% |
| 2014 | 8.87 | 9.43% |
| 2013 | 8.11 | 68.56% |
| 2012 | 4.81 | -16.68% |
| 2011 | 5.77 | -8.80% |
| 2010 | 6.33 | -1.52% |
| 2009 | 6.43 | 8.75% |
| 2008 | 5.91 | -79.83% |
| 2007 | 29.30 | 633.21% |
| 2006 | 4.00 | -95.89% |
| 2005 | 97.34 | 0.00% |
| 2004 | 0.00 | 0.00% |
| 2003 | 0.00 | 0.00% |
| 2002 | 0.00 | 0.00% |
P/S-Verhältnis für ähnliche Unternehmen oder Wettbewerber
| Unternehmen | P/S-Verhältnis | P/S-Verhältnis-Differenz | Land |
|---|---|---|---|
| 3.82 | 25.73% |
US
|
|
| 2.78 | -8.45% |
IE
|
|
| 4.18 | 37.37% |
US
|
|
| 2.97 | -2.35% |
US
|
|
| - | - |
DE
|